Vyteris and Zealand Pharma Announce Agreement on Active Transdermal Patch for Peptide Drugs
April 14, 2009 08:00 ET
|
Vyteris, Inc.
FAIR LAWN, NJ--(Marketwire - April 14, 2009) - Vyteris, Inc. (OTCBB: VYTR), developer of the
first FDA-approved active transdermal drug delivery system and a leader in
active transdermal drug...